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Full-length cDNAs coding for the human GMZ-activator protein has been isolated and characterized. and its genomic structure studied in two 
overlapping clones in ;1-EMBL-4 isolated from a human brain genomic library. Two different cDNAs were found that were identical to the 
5’.terminus to nt 13 I I (counted from the A of the initiation codon. ATG) including the entire Protein coding scqueuce. However, they were entirely 
dissimilar in the 3’-non-coding sequences. The genomic clones covered 94% of the full-length cDNA sequence. Three introns were found. The last 
exon spans contiguously the carboxyl terminus of the protein and the entire 3’.untranslated region of one of the two cDNAs with different 3’.ends. 
The origin of the Y-portion of the other cDNA clone is not clear at this time. 
GMZ-activator protein: Genomic structure; Glycolipid-binding protein 
1. INTRODUCTION 
The GM2 activator protein is a lysosomal glycolipid- 
binding protein of a molecular weight of approximately 
20 kDa. It is an essential component for in vivo degra- 
dation of the GM2 ganglioside by /?-hexosaminidase A 
[I]. Genetic defects in the gene coding for the GM2 
activator protein cause GM2-gangliosidosis AB var- 
iant, a severe, progressive and fatal neurological disor- 
der [l]. Based on the information from purified GM2 
activator and its amino acid sequence [2], a partial 
cDNA clone including the coding sequence of the entire 
mature GM2 activator protein was isolated [3J. In the 
present report we describe sequences of two full-length 
cDNA clones and their partial genomic organization. 
While the two cDNAs both encode an identical protein. 
they differ in the long 3’-untranslated sequences. The 
genomic sequence matches one of the two cDNA se- 
quences. 
2. MATERIALS AND METHODS 
?. I. Scrwtring of cDNA Library 
A cDNA library prepared from cultured fibroblasts of a patient 
who had a juvenile form of Sandhoff disease [4] was screened with the 
Ahhtwi~ttiutrs: /I-hcxosaminidase, B-N-acetyl-D-hcxosaminidasc (EC 
3.2.1.52). 
Corresponhce crr1dre.r.s: K. Sandhoff, Institut fiir Organische Chemic 
und Biochcmie, Gcrhard-Domagk-StraRe I, 5300 Bonn I, Germany. 
Fax: (49) (228) 73-56-83. 
partial cDNA reported earlier [3]. Several clones were isolated, their 
restriction maps evaluated and then sequenced. A few of them in- 
cluded the poly-A tract at the 3’.terminus but none included the 
initiation codon or 5’.untranslated sequence. 
2.2. Atrchord PCR 
Several attempts at obtaining cDNA with the complete 5’.terminus 
by Fcreening cDNA libraries were unsuccessful, and the 5’.most se- 
quence was obtained by the ‘anchored PCR methodology’ (Fig. I) 
[4,5]. Oligonucleotides synthesized were 5’.TGGATCCCCCCCCC- 
CCCCCC (No. 1,5’-end coding strand against poly dG tail with an 
additional BurnHI site), 5’.TCTGCAGGGGTCGCGAGAAGCAA 
(No. 2, non-coding strand of the 5’.terminus of the already known 
sequence with an additional Psll site), 5’.GCTGCAGCTACTGA- 
GCTGGGATG (No. 3, non-coding strand at 20.bp downstream of 
No. 2 with an additional Psrl site). 5’.TCAGGCTTCTGATCACCG 
(No. 4. non-coding strand at 33.bp downstream of No. 3). The first 
rcvcrse transcription was done with the primer No. 4 with AMV 
reverse transcriptase in the presence of 1 unit&l of RNAsin at 42°C 
for 60 min. The DNA product was purified by phenol and chloroform 
extraction and precipitation from ethanol. A polydG tail was 
attached at the 3’.terminus with terminal deoxynuclcotidyl transferase 
and dGTP at 37°C for 30 min. The segment was amplified using the 
primers No. I and No. 3. Finally the amplified products were elec- 
trophorcsed, blotted to a Nylon membrane and screened with the 
oligonucleotide No. 2. The use of 3 different non-coding strand oligo- 
nucleotidcs for reverse transcription. PCR and the final screening was 
empirically necessary to reduce non-specific products. Finally, the 
region of agarosc gel corresponding to the arca of the positive signal 
was excised, DNA extracted and ligated into pUCl8. 
Compctcnt E. co/icells were transformed with the ligation products 
and grown on LB plates overnight at 37°C. Replicas were made with 
a Nylon membrane (ColonyIPlaquc Screen. NEN Research Products, 
Boston, MA). They were denatured in 0.5 N NaOH, neutralized in 1 
M Tris-HCI. pH 7.5, washed in 3 x SSC in 0. I % SDS 3-S times at room 
temperatureand then once at 65°C for 5-6 h. Final screening was with 
the oligonuclcotidc No. 2, as above. 
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Fig. 1. Strategy for anchored PCR to obtain the 5’-terminus. The hatched bar represents the already CxistingcDNA. and the solid line the S-terminus 
being sought. Primer No. 4 was used to synthesize the tirst strand (non-coding). After attaching a G-tail, primers Nos. 1 and 3 were used for PCR 
amplitication of the segment, and finally, the PCR products were screened using the oligonucleotide No. 4. 
2.4. Sequence halysis 
The nucleotide sequence of the insert was determined by thedideoxy 
chain termination method (61 in the double-stranded form in botb 
directions. 
were screened. The probe was labelled with “P by random priming 
(Random Labelling Kit from Pharmacia. Freiburg, Germany). Two 
positive genomic clones were identified and purified according to the 
standard protocol [a]. 
2.5. Isolution of Genornic Clones 
A genomic library was prepared from human brain tissue by the 
method of Frischauf [7]. With the GM2 activator cDNA isolated from 
the plasmid by DamHI digestion as the probe, 2.5 x lb genomic clones 
2.6. Gene Mapping and DNA Sequencing 
The genomic clones were characterized by digesting with appro- 
priate restriction enzymes (Pharmacia, Freiburg, Germany). The frag- 
ments were analyzed by agarose gel electrophoresis, Soutbem blotting 
-58 MGGCACC TCTGCCGCCA CAGACCTTGC ACTTAACTCC GCCCTGACCC ACCCTTCCCG 
1 =CAGTCCC TCATGCAGGC TCCCCTCCTG ATCCCCCTGG GCTTGCTTCT CGCGACCCCT 
61 CCGCAAGCCC ACCTGAAAAA GCCATCCCAG CTCAGTAGCT TTTCCTGGGA TAACTGTGAT 
121 GAAGGGAAGG ACCCTGCGGT GATCAGAAGC CTGACTCTGG AGCCTGACCC CATCGTCGTT 
181 CCTGGAAATG TGACCCTCAG TGTCGTGCGC ACCACCAGTG TCCCCCTGAG TTCTCCTCTG 
241 AAGGTGGATT TAGTTTTGGA GAAGGAGGTG GCTGGCCTCT GGATCAAGAT CCCATGCACA 
301 GACTACATTG GCAGCTGTAC CTTTGAACAC TTCTGTGATG TGCTTGACAT GTTAATTCCT 
361 ACTGGGGAGC CCTGCCCAGA GCCCCTGCGT ACCTATGGGC TTCCTTGCCA CTGTCCCTTC 
421 AAAGAAGGM CCTACTCACT GCCCAAGAGC GAATTCGTTG TGCCTGACCT GGAGCTGCCC 
481 AGTTGGCTCA CCACCGGGAA CTACCCCATA GAGAGCGTCC TGAGCAGCAG TGGGAAGCGT 
5b1 CTGGCCTGCA TCAAGATCW TGCCTCTCTA AAGGGCATAT_EqCATGGCAT CTGCCACAGC 
601 AGAATGGAGC GGTGTGACGA AGGTCCCTTT TCCTCTGTTT TGTGTTTGCC AAGGCCAAAC 
661 TCCCACTCTC TGCCCCCCTT TAATCCCCTT TCTACAGTGA GTCCACTACC CTCACTGAAA 
721 ATCATTTTGT ACCACTTACA TTTTAGGCTG GCGCAAGCAC CCCTCACCTA AGGGAGAATG 
781 AGTTGGACAG TTCTTGATAG CCCAGGGCAT CTGCTGGGCT GACCACGTTA CTCATCCCCG 
8bl TTAACATTCT CTCTAAAGAG CCTCCTTCAT TTCCAAAGCA GTTAAGGAAT GCCAACCAGA 
901 GTGTTTTAGG ACCTGAAGAA TCTTTATCAC TCTCTCTCTT TCACTCTTTT TTTTTTTTGT 
961 CACTAAGTTA AAAGCGAAGT GAGACTATTA ACGTTTTTGT TCTCCTCCGC CCCCCTGTTA 
1021 CAATGAAGGG GCAAAAGTAT TTGCTCTTAG TCTATTCCTC CCTTAACTTC TGTGACTAAT 
1081 TTTTATTTCC TTTCTAGATT TGCCCNLTTA ATACTAGGGT GCAGTGTATC CTGGACAGGT 
1141 AGGGTGTGTG GGGGAGGAAT CCCTTCGCGG ACATATTAGG AGTGCTCTGT TGTTTI\CIULA 
1201 CTCACGGTAC CCGCAGGGCC TACCAAGAGA CTTAAATGAC TGATAAGAAC CGTGAGAAAC 
1261 ATGTTGCTTC CAGCCTTGAT 'TTCGATTTTT CCCTTTTTTT TTTTTTGAGA C 
1312 AGAATCTCAC TTTGTCACCA GGCTGGAGTG CAGTGGTGCA ATCTCACCTC ACTGCAACCT 
1372 CCGCCTCCTG GGTTCAACCA ATTCTCCTGC CTCAGCCTCC CAAGTAGCTT GGACTACAGG 
1432 CCCTGCCACC ACGCCCGGCT AATTTGTGTA TTTTTAGTAG AGATGGCGTT TCACCATGTT 
1492 GGCCAGGATG GTCTCGATCT CTTGACCTCG TGATCTGTCC ACCTTGGCCT TGCAAAGCCC 
1552 TGGATTACAG GCATGAGCCA CTACACCCAG CCGATTTTTC CTTTTTGATT AAAGATGCTA 
1612 TTACAATGTA AATATTTCTT ACACAGiUAC TCACAGCACA TGTGCCCATT GATACAAGGC 
1672 TGCTGAGGCC TGCTCTCCAC TTCGAAATAT AATTAAGGGT GGCAAGGACT GGAGTCAGTT 
1732 GGAGAGTGCA TAGCCAGTCT GTCAAGACAA CTGCCAGATA CTGGCAATAC TCCAGCCTGG 
1792 TGACAGAGTC AGACTCTGTC TC- AGTTTCAATG TTTACTCCTA GAGAAGCCAA 
1052 AAATCCAGAT TTGTATATGA AATCTTACCA TTTTAAMGA TTGGCACCTA ATTATTTTTT 
1912 TMAAAGCTG TGCAGTGTGA TGTGTCCCAA ACGCACTGGC TCATGGGTGG CCACGTCACA 
1972 ACCTCTGATC TCAGACCGTG CATGCCTTGT CCTCTTAACA CARCTCCTCT GGCACCGTTT 
2032 CTCCCTCCAC AGCGCCAAAG CCATACTGTC CGCTCCCAAC GACAAGGCTC TTCCAGTGCT 
2092 ACGAGAGGTA TGAGCAGCCT CTCACCTGTG ACCTGTGGCG ATCACAAGGC TGCCTGCCTC 
2152 AGTCTTGGAG TCCTGTTGGC TGAATGACGC ACATGCGAAA GAGCCTCACC AGCAGCTGCT 
2212 TTTGGAGCAC CGGTCCAAGG AAGAGAGCGT GCCCTCGACA TCAAACTGCC TGGATTTTTC 
2272 TACCACCCTG TTACATCATA ACAACTTCTG AAACACACAC CACCCCTGAC TTCTGGGCTC 
2332 ATTTGAAGCC TGGAATAGCA ATAAATCTTT TTAACTTGCC CACAGTT 
Fig. 2. Nucleotidesequencc of the full-length cDNA coding for the human GM2 activator protein (anchored PCR product plus #4-9). Two potential 
initiation codons and the termination codon are underlined. The stop codon in this sequence is TAA. In some instanecs. TAG was found. There 
is another polymorphism at nt 55 (bold-fact) (A or G). The sequence of k&l0 differs entirely from nt 1312, and it also has one less T in the long 
stretch ofTs just upstream of the diversion point (bold-face). The downstream scqucnce of#6-lOafter thedivcrsion point is not shown here because 
the possibility of its being an artifact cannot be excluded. However. a hard copy of the sequence will be provided upon request. 
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Exon Exon 
no. size 




1 a1 Pro20 >lEOO 
22 
5' CTG AAA AAG (not available for analysis) tgctggctta ttqtccccag CCA TCC CAG 
(2) 
2 162 LYS21 va1u2 7300 
213 244 
5’ CCT CTG AX gtgwcctgg cmtgggtgg qttttatttt tttttaecag GTG GAT TTA 
3 1.32 ~1~142 (3) 
426 
5’ TTC AAA GAA gtaaqtactt agqgaggaga gegcgttaco cctgtgqcta aaqegatggg 
gtttqqagag aagggtcttt gcattctcct tctgcaqatc tgcetgtctc 
tqgatttgta agccagtgtg acctetcaqg aatcacttat cttccqggag 
cctcagttat ccatctacqa aotggqaqac ttqaacttag atqtgatctt 
cagggccctt tatccatata atccatgctc tacaqtqcta tgqccqtctc 
tcatcttgtg cggctgtttt qagaatgqga agagqgqtgg taqttcatgg Glyld3 
ctgcaatcct agcagtggct ctaqgagaaa qaccccatca gtaggctccc 
actgactggc ggtccactgg ctttcccqca q tEz XC TAC 
301 
Fig. 3. Exon/intron junctions of the GM2 activator gene. Exon nucleotides arc written in upper case Ictters. and intron nucleotides in lower case. 
The numbers above the exon sequences refer to the nucleotide numbers in the GM2 cDNA (1 = A of the initiation codon, ATG). Above these 
numbers arc thecorresponding amino acids flanking each intron and their numbers. Intron 3 is relatively short and thecomplcte nucleotide sequence 
is given. On the other hand. the last exon starting from nt 427 is 1951 bp long. 
and hybridization. Fragments ofinterest were isolated with ‘Glasmilk’ 
(Biogen. La Jolla, CA, IJSA) and subcloned into pUCl8. The recom- 
binant plasmid DNA was isolated according to the method of Birn- 
boim and Doly [9]. For sequencing. the plasmid DNA was further 
purified by columns (Qiagen-tip 20, Qiagen, Dusseldorf. Germany). 
The inserts were sequenced by the chain termination method [6]. using 
the T7Sequencing Kit (Pharmacia, Freiburg. Germany) and 
[?%]dATP (Amersham. Braunschweig, Germany). 
3. RESULTS 
3.1. Churacter.ization of Two Different cDNAs 
Two cDNAs different at the 3’-untranslated sequence 
were obtained by screening the cDNA library. Both 
were incomplete at the S’-terminus in that the initiation 
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Fig. 4. Map of the GM2 activator gene. Two overlapping clones were isolated by screening a human genomic library with the cDNA for the 
GMZ-activator. (I) Restriction map of the clones. GM2*3A and GM2*IOA (B = &mHI, E = EcoRI. K = Kpnl, S = S~cl. X = Xl,ol). (II) Sequenced 
regions. (Ill) The intron/cxon organization. The open boxes refer to the exons. The black arca belongs to the untranslated region of the cDNA. 
The putative exon I (in brackets) that covers the missing S-end of the gene is still missing. (IV) The full-length cDNA of the GM2 activator. Exons 
and introns arc indicated as in (111). Position I is the A of the initiation codon, ATG. 
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bered #4-9 and #6-10, respectively. The protein coding 
sequences were identical for both cDNAs. Both had 
long 3’-untranslated sequences which remained identi- 
cal until 729 bases downstream of the termination 
codon, except for an extra T in #4-9 at six bases up- 
stream of the diversion point. From the diversion point, 
the sequences of the two cDNAs were entirely different 
without detectable similarities. 
Seven genuine 5’-terminis of the cDNA clones were 
obtained out of 480 clones screened after the anchored 
PCR procedure. They added 100 nucleotides to :he 
clone #4-9. Two potential in-frame initiation codons 
were found at 59- and 71-bases from the 5’-terminus. 
Since an in-frame termination codon is present at 32-34 
bases. the cDNAs with the sequence added from the 
anchored PCR included the entire protein coding se- 
quence. The combined length of the 5’-terminus and 
#4-9 is 2434 bp ending with a poly-A tract with a 
typical polyadenylation signal (Fig. 2). while that of the 
5’-terminus plus #6-10 is 2034 bp without a typical 
polyadenylation signal or a poly-A tail. Both clones 
code for an identical protein of 194 amino acids and 
have very long 3’untranslated regions - 1794 bp for 
+I-9 and 1394 bp for #&lo. No similarities could be 
detected between the two 3’-untranslated sequences. 
Two polymorphisms were noted: A or G at nt 55 
(Thr or Ala) and TAA or TAG for the termination 
codon. 
3.2. The Genornic Orgnniwtiorz 
The gene coding for the GM2 activator was localized 
earlier on chromosome 5 [lo]. Two overlapping clones 
for the gene of the GM2 activator were isolated from 
the &EMBE4 human genomic library. They were ap- 
propriately digested, subcloned and sequenced. The se- 
quence indicated that the 2 genomic fragments together 
covered 94% of the cDNA sequence, still missing the 
S-most portion of the gene. At least 58 of bp 5’-untrans- 
lated and 8 1 bp translated regions of the cDNA are still 
missing from the isolated genomic fragments. The gene 
coding for the human GM2 activator protein is rela- 
tively small, although the still missing 5’-terminus can 
possibly add a substantial size. The 3’-sequence cor- 
responded to one of the two cDNAs described above 
(#4-9). Among the two polymorphisms noted in the 
cDNA, the stop codon in the genomic clones was TAA. 
The nt 55 of the cDNA was not within the isolated 
genomic sequence. While upstream exons are relatively 
short, the last exon is 1951 bp long from the 5-end to 
the polyadenylation site, spanning contiguously the last 
51 amino acids of the protein and the entire 3’-untrans- 
lated region. 
Three introns were identified. All introns are class 0 
introns. They follow the ag/gt rule for the exon/intron 
boundaries. There is a good homology to the splice 
junctions [l 11. Since the 5’-end of the genomic sequence 
is missing and since the missing portion includes the 
signal sequence which is often coded by its own exon, 
the number of introns may well be larger. From the 
available genomic sequence we can only conclude that 
the incomplete ‘intron 1’ is at least 1800 bp, intron 2 is 
7.3 kb, and intron 3 is 381 bp long (Fig. 3). Intron 3 has 
been sequenced in its entirety, and intron 2 has been 
characterized by restriction digest and hybridization 
studies with oligonucleotides (Fig. 4). The 3’-region 
matches exactly that of the cDNA #4-9. 
4. DISCUSSION 
The partial cDNA we reported earlier included the 
entire coding region of the mature GM2 activator pro- 
tein [3]. Both of the cDNAs described in this report 
included not only the entire protein-coding sequence. 
The 5’-portion obtained by anchored PCR is likely to 
represent the real 5’-terminus because multiple clones 
started from the same nucleotide. There are no exper- 
imental data to indicate which of the 2 initiation co- 
dons which are present only four codons apart, is used 
for translation. This is of no practical consequence be- 
cause the nascent polypeptide is processed proteolyti- 
tally at the N-terminal end to generate the mature acti- 
vator protein starting at amino acid 32 (Ser) counted 
from the first methionine. 
The origins of the two cDNAs with different 3’-un- 
translated sequences are of some interest. The 3’-un- 
translated sequence of #4-9 exactly matches the ge- 
nomic sequence while that of #6-10 does not. Since the 
last portion of the coding region and the entire non- 
coding region of #4-9 are contiguous as a single exon. 
#6-10 cannot have been derived from hnRNA with an 
intron yet to be spliced out. The availabale data only 
allow us to conclude that #4-9 with the additional S- 
sequence represents the full-length cDNA coding for the 
GM2 activator protein but that the origin of the 3’- 
untranslated region of #6-10 is unclear. The possibility 
of this clone being an artifact cannot yet be excluded. 
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